Eyeing Enzalutamide for Hormone-Sensitive Prostate Cancer

Cancer Discovery - United States
doi 10.1158/2159-8290.cd-nb2019-035
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors

Unknown

Publisher

American Association for Cancer Research (AACR)

Related search

Identification of a Radiosensitivity Molecular Signature Induced by Enzalutamide in Hormone-Sensitive and Hormone-Resistant Prostate Cancer Cells

Scientific Reports
Multidisciplinary
2019English

‘Charting a New Course for Prostate Cancer’ – Currying Favor for Docetaxel in Hormone-Sensitive Metastatic Prostate Cancer

Expert Review of Anticancer Therapy
OncologyPharmacology
2014English

Chemohormonal Therapy for Metastatic Hormone-Sensitive Prostate Cancer: An Asian Perspective

Asia-Pacific Journal of Clinical Oncology
MedicineOncology
2018English

Initial Experience of the Enzalutamide Treatment for Castration-Resistant Prostate Cancer

Japanese Journal of Urology
Urology
2016English

Metastatic Castration-Resistant Prostate Cancer: Critical Review of Enzalutamide

Clinical Medicine Insights: Oncology
Oncology
2013English

Cost-Effectiveness of Metastasis-Directed Therapy in Oligorecurrent Hormone-Sensitive Prostate Cancer

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2019English

Hormone-Refractory Prostate Cancer

English

A Pyrrole-Imidazole Polyamide Is Active Against Enzalutamide-Resistant Prostate Cancer

Cancer Research
Cancer ResearchOncology
2017English

The Evolving Role of Enzalutamide on the Treatment of Prostate Cancer

Future Oncology
MedicineCancer ResearchOncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy